Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung CancerLeora Horn, Christine M. Lovly, Huan Qiao et al.|Journal of Thoracic Oncology|2019Cited by 163
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor MalignanciesMelissa L. Johnson, Alexander I. Spira, Anthony B. El-Khoueiry et al.|Clinical Cancer Research|2021Cited by 61